In a year dominated by the resurgence of the technology sector, a curious question emerges on the minds of investors: is it time to reconsider the balance between the soaring heights of technology stocks and the seemingly downtrodden biotech industry? The contrasting fortunes of these two sectors have caught the attention of market analysts, raising ... Read more